sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Infectious Disease Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00016883
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 193
Buy Now

Infectious Disease Therapeutics Market Analysis 2021 to 2031

Buy Now

Infectious Disease Therapeutics Market Report Infectious Disease Therapeutics Market Size and Share Infectious Disease Therapeutics Market Scope and Analysis

Infectious Disease Therapeutics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1,19,708.77 Million
Market Size by 2030 US$ 1,67,883.93 Million
Global CAGR (2022 - 2030) 4.3%
Historical Data 2020-2021
Forecast period 2022-2030
Segments Covered By Drug Class
  • Anti-viral
  • Anti Bacterial
  • Anti-Fungal
By Indication
  • HIV
  • Hepatitis
  • Tuberculosis
  • Influenza
  • HPV
By Route of Administration
  • Oral
  • Parenteral
  • Topical
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer Inc
  • Gilead Sciences Inc
  • F Hoffmann La Roche Ltd
  • Shionogi Co Ltd
  • Bayer AG
  • BioCryst Pharmaceuticals Inc
  • GSK Plc
  • AbbVie Inc
  • Merck Co Inc
  • Astellas Pharma Inc
    		•